Iryna Ethell, PhD, at University of California

Role of Matrix Metalloproteinases (MMP-9) in Fragile X

February 2, 2009

With a $220,000 FRAXA grant, Dr. Iryna Ethell’s team at UC Riverside uncovered MMP-9’s role in Fragile X—leading to a major treatment strategy using minocycline.

Read More »

3 Researchers Honored at FRAXA Investigators Meeting

October 4, 2008

FRAXA’s 2008 Investigators Meeting brought together 150+ researchers from around the world to collaborate and speed new Fragile X therapies.

Read More »
Iryna Ethell, PhD, at University of California

Researchers Propose Minocycline to Treat Fragile X

October 4, 2008

Researchers found that minocycline, an available drug that blocks MMP-9, may improve Fragile X symptoms. This discovery inspired clinical trials.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (42)